Jade Biosciences appoints Brad Dahms as CFO
Source: SeekingAlpha
2025-07-01 07:28:28 ET
More on Jade Biosciences, Inc.
- Historical earnings data for Jade Biosciences, Inc.
- Dividend scorecard for Jade Biosciences, Inc.
- Financial information for Jade Biosciences, Inc.
Read the full article on Seeking Alpha
For further details see:
Jade Biosciences appoints Brad Dahms as CFO
Jade Biosciences Inc.
NASDAQ: JBIO
JBIO Trading
6.2% G/L:
$14.485 Last:
187,309 Volume:
$14.79 Open:
JBIO Latest News
March 06, 2026 07:00:00 am
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
January 05, 2026 07:00:00 am
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
November 13, 2025 04:05:00 pm
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
JBIO Stock Data
$715,551,030
29,613,259
1.73%
28
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
